Diagnostics & Research
The Diagnostics & Research industry has a total of 44 stocks, with a combined market cap of $939.51 billion, total revenue of $175.19 billion and a weighted average PE ratio of 49.06.
Market Cap
939.51B
Revenue
175.19B
Profits
19.15B
PE Ratio
49.06
Profit Margin
10.93%
Dividend Yield
0.18%
44 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 258.55B | -1.40% | 955,362 | 47.35B |
| 2 | DHR | Danaher Corporation | 163.07B | -2.19% | 1,947,499 | 25.61B |
| 3 | NTRA | Natera, Inc. | 59.53B | -5.28% | 831,727 | 2.71B |
| 4 | A | Agilent Technologies, Inc. | 49.26B | -3.55% | 1,262,173 | 7.37B |
| 5 | WAT | Waters Corporation | 45.41B | -3.73% | 605,533 | 4.64B |
| 6 | IDXX | IDEXX Laboratories, Inc. | 44.36B | -2.24% | 284,817 | 4.55B |
| 7 | IQV | IQVIA Holdings Inc. | 43.80B | -3.37% | 454,530 | 17.31B |
| 8 | ILMN | Illumina, Inc. | 35.57B | -18.80% | 3,026,646 | 4.54B |
| 9 | MTD | Mettler-Toledo International Inc. | 33.78B | -1.89% | 67,218 | 4.13B |
| 10 | LH | Labcorp Holdings Inc. | 29.27B | -2.08% | 337,264 | 14.59B |
| 11 | DGX | Quest Diagnostics Incorporated | 27.74B | -0.30% | 280,601 | 11.84B |
| 12 | GH | Guardant Health, Inc. | 23.81B | -4.25% | 570,004 | 1.18B |
| 13 | MEDP | Medpace Holdings, Inc. | 18.22B | -3.85% | 84,316 | 2.84B |
| 14 | RVTY | Revvity, Inc. | 17.48B | -5.48% | 1,057,948 | 2.91B |
| 15 | CRL | Charles River Laboratories International, Inc. | 16.97B | -5.46% | 681,185 | 4.00B |
| 16 | ICLR | ICON Public Limited Company | 15.72B | -2.64% | 1,452,250 | 8.23B |
| 17 | QGEN | Qiagen N.V. | 10.40B | -0.08% | 2,117,404 | 2.10B |
| 18 | GRAL | GRAIL, Inc. | 6.35B | -10.48% | 588,986 | 165.26M |
| 19 | RDNT | RadNet, Inc. | 5.69B | -1.86% | 180,506 | 2.27B |
| 20 | BLLN | BillionToOne, Inc. | 5.29B | -2.34% | 205,739 | 397.41M |
| 21 | SHC | Sotera Health Company | 5.13B | -3.80% | 655,507 | 1.22B |
| 22 | CDNA | CareDx, Inc. | 4.52B | 22.26% | 2,155,457 | 497.40M |
| 23 | ADPT | Adaptive Biotechnologies Corporation | 4.22B | -6.18% | 1,854,893 | 308.08M |
| 24 | VCYT | Veracyte, Inc. | 4.04B | -3.76% | 329,789 | 561.90M |
| 25 | NEO | NeoGenomics, Inc. | 2.23B | -3.85% | 673,833 | 787.75M |
| 26 | WGS | GeneDx Holdings Corp. | 2.02B | -4.48% | 510,339 | 454.43M |
| 27 | PSNL | Personalis, Inc. | 1.68B | -1.51% | 1,065,577 | 69.67M |
| 28 | FRNM | Freenome, Inc. | 1.32B | -4.43% | 451,608 | 35.41M |
| 29 | OPK | OPKO Health, Inc. | 1.24B | 0.30% | 1,219,472 | 587.90M |
| 30 | CSTL | Castle Biosciences, Inc. | 1.13B | -3.56% | 123,362 | 357.28M |
| 31 | MYGN | Myriad Genetics, Inc. | 609.29M | -4.50% | 496,488 | 806.60M |
| 32 | FLGT | Fulgent Genetics, Inc. | 572.87M | -3.97% | 70,954 | 323.93M |
| 33 | BDSX | Biodesix, Inc. | 245.31M | -5.95% | 43,538 | 102.94M |
| 34 | XGN | Exagen Inc. | 202.77M | -3.79% | 224,286 | 71.12M |
| 35 | BNR | Burning Rock Biotech Limited | 110.89M | -4.84% | 7,988 | 73.70M |
| 36 | IMDX | Insight Molecular Diagnostics Inc. | 97.19M | -6.60% | 21,057 | 1.67M |
| 37 | QUCY | Quantum Cyber N.V. | 72.34M | -5.44% | 192,305 | 537.08K |
| 38 | PRPO | Precipio, Inc. | 33.88M | -2.18% | 15,927 | 27.20M |
| 39 | MDXH | MDxHealth SA | 15.84M | -8.39% | 796,528 | 114.02M |
| 40 | NDRA | ENDRA Life Sciences Inc. | 7.29M | -0.41% | 9,386 | - |
| 41 | XWEL | XWELL, Inc. | 6.06M | 2.23% | 33,765 | 28.28M |
| 42 | ADVB | Advanced Biomed Inc. | 4.13M | -5.30% | 8,635 | 127.64K |
| 43 | BIAF | bioAffinity Technologies, Inc. | 3.78M | -2.81% | 41,348 | 5.90M |
| 44 | ISPC | iSpecimen Inc. | 2.04M | 2.23% | 436,097 | 466.30K |